Athanor Capital, LP Adaptimmune Therapeutics PLC Transaction History

Athanor Capital, LP

  • $24.6 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$4.9 - $6.83 $476,476 - $664,149
-97,240 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$4.0 - $9.2 $137,968 - $317,326
34,492 Added 54.97%
97,240 $524,000
Q3 2020

Nov 16, 2020
SELL
$7.66 - $10.78 $226,169 - $318,290
-29,526 Reduced 32.0%
62,748 $501,000
Q2 2020

Aug 13, 2020
BUY
$2.58 - $12.1 $238,066 - $1.12 Million
92,274 New
92,274 $924,000

Others Institutions Holding ADAP

# of Institutions
83
Shares Held
150M
Call Options Held
60.8K
Put Options Held
5.8K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $118M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Athanor Capital, LP Portfolio

Follow Athanor Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athanor Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email